Sano, S., Kubo, H., Morishima, H., Goto, R., Zheng, R., & Nakagawa, H. (2018). Guselkumab, a human interleukin‐23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52‐week, phase 3, multicenter, open‐label study. J Dermatol.

Sano, Shigetoshi, Hiroshi Kubo, Hitomi Morishima, Ryosuke Goto, Richuan Zheng, e Hidemi Nakagawa. "Guselkumab, a Human Interleukin‐23 Monoclonal Antibody in Japanese Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis: Efficacy and Safety Analyses of a 52‐week, Phase 3, Multicenter, Open‐label Study." J Dermatol 2018.

Sano, Shigetoshi, et al. "Guselkumab, a Human Interleukin‐23 Monoclonal Antibody in Japanese Patients With Generalized Pustular Psoriasis and Erythrodermic Psoriasis: Efficacy and Safety Analyses of a 52‐week, Phase 3, Multicenter, Open‐label Study." J Dermatol 2018.